Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research

Center for Translational Cancer Nanomedicine
Northeastern University

Center Overview

The main objective of the Center for Translational Cancer Nanomedicine is to develop, test pre-clinically in vitro and in vivo, characterize, scale up, and manufacture under Good Manufacturing Practice (GMP) conditions test batches of the most promising nanopreparations for cancer, with a particular focus on lung, ovarian, and pancreatic cancer. Nanocarriers will include polymeric micelles, liposomes, polymeric particles, and dendrimers, while the drugs to be used will include pro-apoptotic agents, DNA, and siRNA together with diagnostic labels.

Center Investigators

Vladimir Torchilin, Ph.D., D.Sc.
Principal Investigator


Nahum Goldberg, M.D.
Principal Investigator

For more information about the Center for Translational Cancer Nanomedicine visit our website at:

View all Alliance News